Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soff

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
Circulation|August 14, 2014
Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signalingChiara Giannarelli, Matilde Alique, David T Rodriguez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African AmericansJ Matthew Reinersman, Melissa L Johnson, Gregory J Riely, et al.
BMC Gastroenterology|October 7, 2025
Heterogeneity of treatment preferences in the absence of guideline recommendations - a case vignette study in colorectal cancer tumor boards in Germany, Austria and SwitzerlandJohannes Soff, Stefan Rolf Benz, Christoph Kowalski, et al.
Thrombosis and Haemostasis|September 22, 2017
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI TrialAlok A Khorana, Saroj Vadhan-Raj, Nicole M Kuderer, et al.
The Oncologist|May 12, 2023
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future DirectionTzu-Fei Wang, Alok A Khorana, Giancarlo Agnelli, et al.
Annals of Neurology|May 24, 2021
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective StudyBabak B Navi, Carla P Sherman, Richard Genova, et al.
Blood|December 3, 2020
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumorsAndrew Dunbar, Kelly L Bolton, Sean M Devlin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
Cancer- and chemotherapy-induced anemiaGeorge M Rodgers, Pamela Sue Becker, Morey Blinder, et al.
Blood Advances|November 21, 2022
Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantationMichael Scordo, Leah J Gilbert, Danielle M Hanley, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Circulation|August 14, 2014
Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signalingChiara Giannarelli, Matilde Alique, David T Rodriguez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African AmericansJ Matthew Reinersman, Melissa L Johnson, Gregory J Riely, et al.
BMC Gastroenterology|October 7, 2025
Heterogeneity of treatment preferences in the absence of guideline recommendations - a case vignette study in colorectal cancer tumor boards in Germany, Austria and SwitzerlandJohannes Soff, Stefan Rolf Benz, Christoph Kowalski, et al.
Thrombosis and Haemostasis|September 22, 2017
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI TrialAlok A Khorana, Saroj Vadhan-Raj, Nicole M Kuderer, et al.
The Oncologist|May 12, 2023
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future DirectionTzu-Fei Wang, Alok A Khorana, Giancarlo Agnelli, et al.
Annals of Neurology|May 24, 2021
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective StudyBabak B Navi, Carla P Sherman, Richard Genova, et al.
Blood|December 3, 2020
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumorsAndrew Dunbar, Kelly L Bolton, Sean M Devlin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
Cancer- and chemotherapy-induced anemiaGeorge M Rodgers, Pamela Sue Becker, Morey Blinder, et al.
Blood Advances|November 21, 2022
Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantationMichael Scordo, Leah J Gilbert, Danielle M Hanley, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Pageof 21